• LOGIN
  • SUBSCRIBE
  • FREE E-Newsletter/Product Bulletins

Cath Lab Digest

  • Follow us on
  • Home
  • About Us
    • Privacy Policy/Copyright
    • About VDM
  • Issues
    • Current Issue
    • Issue Archives
  • Editor's Update
  • Advertise
  • Reprints
  • Authors
    • Author Instructions
    • Submission Portal
  • Reviewers
  • Contact

Search

CoreValve Transfemoral Approach

  • Thu, 3/4/10 - 9:30am
  • 0 Comments
  • 5269 reads


Introduction

Transcatheter aortic valve implantation (TAVI) was first performed by Alain Cribier in 20021 using the balloon-expandable Cribier-Edwards valve. Soon after, the self-expandable CoreValve ReValving system (Medtronic, Inc., Minneapolis, Minnesota) was introduced based on a completely different design concept.2 Initial reports on safety and technical feasibility of these two new technologies raised expectations among interventional cardiologists,3–5 and both prostheses have undergone rapid development and implementation t



Read the full story >>

Edwards-SAPIEN Aortic Valve Transapical Approach

  • Wed, 3/3/10 - 10:16pm
  • 0 Comments
  • 5696 reads


Abstract

The Edwards-SAPIEN aortic valve (Edwards Lifesciences, Irvine, California) transapical approach was introduced into clinical practice in 2005. After feasibility studies, CE mark was obtained by the end of 2007. It is applied in operations on high-risk patients with calcific aortic valve stenosis, and allows for a less invasive replacement of the diseased native valve. Initially, patients were placed on cardiopulmonary bypass as a safety net, but improvements in periprocedural management soon allowed for truly off-pump implantation of these prostheses.
The fol



Read the full story >>

  • Advertise your Job Here
    For information on posting classified ads, please contact:
    Alex Dulnikowski, Classified Sales Manager
    (800) 237-7285, ext. 205

vdm Blogs

PROTECT carotid stent trial provides further evidence that CAS is getting better and becoming more competitive with CEA

Frank J Criado MD FACS FSVM

A New Algorithm to Treat Patients with Peripheral Vascular Disease

Robert S. Dieter MD RVT and Aravinda Nanjundappa MD RVT

In-Stent Restenosis in the SFA Remains a Significant Unresolved Problem

Frank J Criado MD FACS FSVM

Support Comes From Many Directions

Richard R. Heuser MD FACC FACP FESC FSCAI

Pedal Artery Access: Advances in Management of Critical limb ischemia

Robert S. Dieter MD RVT and Aravinda Nanjundappa MD RVT
more »

Vascular Newswire

  • Boston Scientific Launches Innovative Crossing Device to Treat Complete Blockages in Peripheral Arteries
    Fri, 02/10/12 - 11:12am
  • Stereotaxis Announces European Adoption Milestone and Health Canada Market Clearance for Vdrive System
    Fri, 02/10/12 - 11:08am
  • Medtronic Stent Resulted in 90% Freedom from Reinterventions in Narrowed Leg Arteries at 12 Months in International Study
    Thu, 02/09/12 - 10:52am
  • AngioDynamics Launches DuraFlow 2 Chronic Hemodialysis Catheter
    Wed, 02/08/12 - 10:18am
more »

Clinical Events Calendar

  • American Venous Forum 24th Annual Meeting
    Wed, 02/08/2012 - Sat, 02/11/2012
    Orlando, FL, United States
  • JIM 2012
    Thu, 02/09/2012 - Sat, 02/11/2012
    Rome, Italy
  • Cardiovascular Care Update 2012 (CVC)
    Fri, 02/10/2012 - Sat, 02/11/2012
    Scottsdale, AZ, United States
more »

Poll

How do you feel about the continued practice of screening patients for asymptomatic CAD?:
REVIEW OUR OTHER Cardiology BRANDS

Our other resources for healthcare professionals.

HMP Communications © 2012 HMP Communications

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC. ©2012 HMP Communications